- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07596836
Sprint Interval Training in Young Sedentary Adults (SIT)
Effects of Sprint Interval Training on Cardiovascular Capacity and VO2max in Young Sedentary Adults: A Randomized Controlled Trial
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
This study was designed as a randomized controlled pre-test and post-test intervention study. Healthy sedentary adults aged 20 to 25 years were enrolled after ethics approval and written informed consent. Participants were randomly allocated in a 1:1 ratio to either a supervised sprint interval training group or a control group.
The sprint interval training group performed supervised exercise sessions on a cycle ergometer three times per week for 6 weeks. Each session included a 5-minute warm-up, followed by repeated 30-second all-out sprint bouts with active recovery periods. The number of sprint repetitions was progressively increased during the intervention period. The control group maintained their usual sedentary lifestyle and did not receive an additional exercise program.
Outcome measurements were performed before and after the intervention. The primary outcome was VO2max, assessed using a maximal exercise test on a cycle ergometer with respiratory gas analysis. Secondary outcomes were resting heart rate and 6-minute walk test distance. Adherence and adverse events were monitored throughout the study period.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Ankara
-
Ankara, Ankara, Turchia (Türkiye), 06000
- Ankara Demirspor
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Aged 20-25 years
- Healthy sedentary adult
- Engaging in less than 150 minutes/week of moderate-to-vigorous physical activity
- IPAQ score below 600 MET-min/week or not participating in a regular exercise program
- Willing to provide written informed consent
Exclusion Criteria:
- History of cardiovascular, pulmonary, or metabolic disease, such as hypertension or diabetes
- Musculoskeletal injury or orthopedic condition preventing exercise participation
- Pregnancy or breastfeeding
- Smoking
- Regular medication use
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Sprint Interval Training Group
Participants in this group completed supervised sprint interval training sessions on a cycle ergometer three times per week for 6 weeks.
|
The sprint interval training intervention consisted of supervised cycle-ergometer sessions performed three times per week for 6 weeks.
Each session included a 5-minute warm-up at 50% VO2max, followed by 4 to 6 repetitions of 30-second all-out sprint bouts on a Monark 894E cycle ergometer, with 4-minute active recovery periods between sprints.
The number of sprint repetitions was progressively increased from 4 repetitions in the first two weeks to 6 repetitions in the following four weeks.
Altri nomi:
|
|
Nessun intervento: Control Group
Participants in this group maintained their usual sedentary routine and did not receive an additional exercise program during the study period.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Maximal Oxygen Uptake (VO2max)
Lasso di tempo: Baseline and 6 weeks
|
VO2max was assessed using a maximal exercise test on a cycle ergometer with breath-by-breath respiratory gas analysis.
VO2max values were recorded in ml/kg/min before and after the 6-week intervention.
|
Baseline and 6 weeks
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Resting Heart Rate
Lasso di tempo: Baseline and 6 weeks
|
Resting heart rate was measured in the morning after 10 minutes of seated rest using a heart rate monitor.
Values were recorded in beats per minute before and after the 6-week intervention.
|
Baseline and 6 weeks
|
|
Change in 6-Minute Walk Test Distance
Lasso di tempo: Baseline and 6 weeks
|
Functional exercise capacity was assessed using the 6-minute walk test.
The total distance covered in 6 minutes was recorded in meters before and after the 6-week intervention.
|
Baseline and 6 weeks
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Sezer Taştan, phD, Ankara Demirspor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- ST-SIT-VO2MAX-2026
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .